Elicio Therapeutics, Inc.
ELTX • NASDAQ • Stock Fundamentals
Elicio Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Robert T. Connelly, with a market cap of $191.4M.
Market Cap$191.4M
Employees32.0
CEORobert T. Connelly
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 11, 2026 · 17 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsQ2 2026
Financials
Based on Q1 2026 filing
Elicio Therapeutics, Inc. FAQ
Common questions about Elicio Therapeutics, Inc.
Elicio Therapeutics, Inc. (ELTX) has a market capitalization of $191.4M and trades on NASDAQ.
Elicio Therapeutics, Inc. has approximately 32 employees.